You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 8, August 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Primary Squamous Cell Carcinoma of the Parotid Gland

Robert K. Gaughan, MD; Kerry D. Olsen, MD; Jean E. Lewis, MD; WILLIAM J. RICHTSMEIER, MD, PHD

Arch Otolaryngol Head Neck Surg. 1992;118(8):798-801.


Abstract

• We reviewed all cases of possible primary squamous cell carcinoma of the parotid gland treated at Mayo Clinic, Rochester, Minn, from 1960 through 1988. Eighteen cases of primary squamous cell carcinoma of the parotid gland were identified. We report the clinical behavior and results of treatment of these rare parotid gland neoplasms. The age at diagnosis ranged from 48 to 86 years; the majority of patients were aged 65 years or older. Half of the patients presented with an asymptomatic parotid gland mass; a painful mass occurred in 33% of patients. Facial paralysis was noted in 17%, and a neck mass was the presenting symptom in 11% of patients. All patients underwent parotidectomy, and all or part of the facial nerve was sacrificed in 66% of patients. A neck dissection was performed in 12 patients, five of whom had pathologic confirmation of neck metastasis. Adjunctive radiation therapy was performed in 55% of patients. The overall survival at 5 years was 50%. Deep fixation and facial nerve paralysis were associated with a poor prognosis. Most recurrences developed within 1 year of initial treatment. Regional recurrence was always associated with a rapid death. Our data suggest that aggressive treatment and early detection may result in a better prognosis than is commonly associated with these tumors.

(Arch Otolaryngol Head Neck Surg. 1992;118:798-801)



Author Affiliations

Durham, NC

From the Department of Otorhinolaryngology (Drs Gaughan and Olsen) and the Section of Surgical Pathology (Dr Lewis), Mayo Clinic and Mayo Foundation, Rochester, Minn.


Footnotes

Accepted for publication April 8, 1992.

Presented at the annual meeting of the American Society for Head and Neck Surgery, Waikoloa, Hawaii, May 9, 1991.

Reprint requests to the Department of Otorhinolaryngology, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (Dr Olsen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nodal Metastasis in Major Salivary Gland Cancer: Predictive Factors and Effects on Survival
Bhattacharyya and Fried
Arch Otolaryngol Head Neck Surg 2002;128:904-908.
ABSTRACT | FULL TEXT  

The National Cancer Data Base Report on Cancer of the Head and Neck
Hoffman et al.
Arch Otolaryngol Head Neck Surg 1998;124:951-962.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.